Need professional-grade analysis? Visit stockanalysis.com
$3.21B
21.32
6,365
0.40%
Virbac SA (VIRP) trades on Euronext Paris in EUR. The company is classified in the Healthcare sector under the Drug Manufacturers - General industry. The stock currently trades at EUR383.50, up 5.94% from the previous close.
Over the past year, VIRP has traded between a low of EUR296.26 and a high of EUR383.50. The stock has gained 29.4% over this period. It is currently 29.4% above its 52-week low.
Virbac SA has a market capitalization of $3.21B, with a price-to-earnings ratio of 21.32 and a dividend yield of 0.40%.
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific. The company offers a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. It serves veterinarians, farmers, and pet owners. The company was founded in 1968 and is headquartered in Carros, France.
Side-by-side comparison against top Healthcare peers.